25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

SAVA (Cassava Sciences Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Cassava Sciences Inc together

I guess you are interested in Cassava Sciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Cassava Sciences Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Cassava Sciences Inc’s Price Targets

I'm going to help you getting a better view of Cassava Sciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Cassava Sciences Inc

I send you an email if I find something interesting about Cassava Sciences Inc.

1. Quick Overview

1.1. Quick analysis of Cassava Sciences Inc (30 sec.)










1.2. What can you expect buying and holding a share of Cassava Sciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.82
Expected worth in 1 year
$-0.27
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$-2.09
Return On Investment
-100.5%

For what price can you sell your share?

Current Price per Share
$2.08
Expected price per share
$2.04 - $2.43
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Cassava Sciences Inc (5 min.)




Live pricePrice per Share (EOD)
$2.08
Intrinsic Value Per Share
$-14.34 - $1.94
Total Value Per Share
$-12.52 - $3.77

2.2. Growth of Cassava Sciences Inc (5 min.)




Is Cassava Sciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$87.9m$140m-$8m-6.1%

How much money is Cassava Sciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$30.7m-$3.8m-$26.9m-87.5%
Net Profit Margin-564.6%-222.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Cassava Sciences Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#339 / 853

Most Revenue
#524 / 853

Most Profit
#694 / 853

Most Efficient
#599 / 853
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Cassava Sciences Inc?

Welcome investor! Cassava Sciences Inc's management wants to use your money to grow the business. In return you get a share of Cassava Sciences Inc.

First you should know what it really means to hold a share of Cassava Sciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Cassava Sciences Inc is $2.08. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cassava Sciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cassava Sciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.82. Based on the TTM, the Book Value Change Per Share is $-0.52 per quarter. Based on the YOY, the Book Value Change Per Share is $0.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cassava Sciences Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.92-44.0%-0.64-30.6%-0.08-3.8%-0.39-19.0%-0.31-15.0%-0.18-8.7%
Usd Book Value Change Per Share-0.82-39.5%-0.52-25.1%0.052.4%-0.22-10.8%0.073.2%0.031.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.82-39.5%-0.52-25.1%0.052.4%-0.22-10.8%0.073.2%0.031.3%
Usd Price Per Share1.81-8.78-17.95-18.91-27.33-14.91-
Price to Earnings Ratio-0.49--3.76-3.30--5.72--35.57--25.86-
Price-to-Total Gains Ratio-2.21--18.83--26.51--27.68--224.91--123.85-
Price to Book Ratio0.99-2.72-7.18-5.70-7.55-7.73-
Price-to-Total Gains Ratio-2.21--18.83--26.51--27.68--224.91--123.85-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.08
Number of shares480
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.520.07
Usd Total Gains Per Share-0.520.07
Gains per Quarter (480 shares)-250.8931.69
Gains per Year (480 shares)-1,003.57126.76
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1004-10140127117
20-2007-20180254244
30-3011-30220380371
40-4014-40260507498
50-5018-50300634625
60-6021-60340761752
70-7025-70380887879
80-8029-8042010141006
90-9032-9046011411133
100-10036-10050012681260

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%2.010.00.016.7%2.018.00.010.0%2.038.00.05.0%13.089.00.012.7%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%4.016.00.020.0%8.032.00.020.0%38.064.00.037.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%2.00.0100.02.0%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%4.016.00.020.0%8.032.00.020.0%40.062.00.039.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Cassava Sciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.821-0.523-36%0.050-1748%-0.225-73%0.066-1343%0.027-3148%
Book Value Per Share--1.8212.732-33%2.899-37%3.274-44%3.673-50%2.035-11%
Current Ratio--2.4266.668-64%5.891-59%10.498-77%24.034-90%20.684-88%
Debt To Asset Ratio--0.3500.194+81%0.228+53%0.160+119%0.108+224%0.088+298%
Debt To Equity Ratio--0.5390.267+102%0.371+45%0.233+131%0.153+253%0.113+376%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--152407480.000518299617.750-71%974911535.250-84%1037792634.333-85%1470674235.800-90%804848574.450-81%
Eps---0.915-0.637-30%-0.080-91%-0.394-57%-0.312-66%-0.181-80%
Ev To Ebitda Ratio---0.843-4.221+400%-9.478+1024%-10.421+1136%-41.403+4809%-29.648+3415%
Free Cash Flow Per Share---0.102-0.496+385%-0.447+336%-0.448+337%-0.364+256%-0.201+96%
Free Cash Flow To Equity Per Share---0.102-0.491+380%0.201-151%-0.146+43%-0.109+7%-0.055-47%
Gross Profit Margin--1.0001.047-4%0.778+29%0.942+6%1.009-1%1.0040%
Intrinsic Value_10Y_max--1.945----------
Intrinsic Value_10Y_min---14.336----------
Intrinsic Value_1Y_max---0.659----------
Intrinsic Value_1Y_min---1.741----------
Intrinsic Value_3Y_max---1.329----------
Intrinsic Value_3Y_min---4.999----------
Intrinsic Value_5Y_max---1.215----------
Intrinsic Value_5Y_min---7.976----------
Market Cap100480432.000+13%87437480.000423901867.750-79%867006035.250-90%913381634.333-90%1320375685.800-93%720307024.450-88%
Net Profit Margin----5.6460%-2.2270%799.737-100%4022.842-100%1843.873-100%
Operating Margin----5.6460%-2.4260%966.615-100%4190.969-100%1908.225-100%
Operating Ratio---5.024-100%2.426-100%-984.8310%-4280.1490%-1952.8020%
Pb Ratio1.142+13%0.9942.719-63%7.180-86%5.696-83%7.554-87%7.729-87%
Pe Ratio-0.568-15%-0.494-3.755+660%3.297-115%-5.720+1057%-35.571+7096%-25.864+5133%
Price Per Share2.080+13%1.8108.775-79%17.948-90%18.908-90%27.333-93%14.911-88%
Price To Free Cash Flow Ratio-5.078-15%-4.419-6.472+46%-10.176+130%-11.842+168%-41.251+834%-32.654+639%
Price To Total Gains Ratio-2.535-15%-2.206-18.828+754%-26.507+1102%-27.683+1155%-224.909+10097%-123.852+5515%
Quick Ratio--2.3926.261-62%5.574-57%9.982-76%23.394-90%20.426-88%
Return On Assets---0.327-0.198-39%-0.025-92%-0.108-67%-0.082-75%-0.106-68%
Return On Equity---0.503-0.261-48%0.008-6075%-0.120-76%-0.090-82%-0.116-77%
Total Gains Per Share---0.821-0.523-36%0.050-1748%-0.225-73%0.066-1343%0.027-3148%
Usd Book Value--87973000.000131983000.000-33%140038500.000-37%158141833.333-44%177424300.000-50%98314550.000-11%
Usd Book Value Change Per Share---0.821-0.523-36%0.050-1748%-0.225-73%0.066-1343%0.027-3148%
Usd Book Value Per Share--1.8212.732-33%2.899-37%3.274-44%3.673-50%2.035-11%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--152407480.000518299617.750-71%974911535.250-84%1037792634.333-85%1470674235.800-90%804848574.450-81%
Usd Eps---0.915-0.637-30%-0.080-91%-0.394-57%-0.312-66%-0.181-80%
Usd Free Cash Flow---4947000.000-23979500.000+385%-21576500.000+336%-21620416.667+337%-17604100.000+256%-9691326.900+96%
Usd Free Cash Flow Per Share---0.102-0.496+385%-0.447+336%-0.448+337%-0.364+256%-0.201+96%
Usd Free Cash Flow To Equity Per Share---0.102-0.491+380%0.201-151%-0.146+43%-0.109+7%-0.055-47%
Usd Market Cap100480432.000+13%87437480.000423901867.750-79%867006035.250-90%913381634.333-90%1320375685.800-93%720307024.450-88%
Usd Price Per Share2.080+13%1.8108.775-79%17.948-90%18.908-90%27.333-93%14.911-88%
Usd Profit---44224000.000-30791750.000-30%-3843000.000-91%-18587833.333-58%-14757250.000-67%-8589175.000-81%
Usd Revenue---305500.000-100%587000.000-100%297350.000-100%178400.000-100%89202.600-100%
Usd Total Gains Per Share---0.821-0.523-36%0.050-1748%-0.225-73%0.066-1343%0.027-3148%
 EOD+5 -3MRQTTM+10 -25YOY+10 -253Y+10 -265Y+9 -2710Y+7 -29

3.3 Fundamental Score

Let's check the fundamental score of Cassava Sciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.568
Price to Book Ratio (EOD)Between0-11.142
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.392
Current Ratio (MRQ)Greater than12.426
Debt to Asset Ratio (MRQ)Less than10.350
Debt to Equity Ratio (MRQ)Less than10.539
Return on Equity (MRQ)Greater than0.15-0.503
Return on Assets (MRQ)Greater than0.05-0.327
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Cassava Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.687
Ma 20Greater thanMa 502.180
Ma 50Greater thanMa 1002.232
Ma 100Greater thanMa 2002.083
OpenGreater thanClose2.100
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Cassava Sciences Inc

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. Cassava Sciences, Inc. was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.

Fundamental data was last updated by Penke on 2025-09-05 07:42:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Cassava Sciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Cassava Sciences Inc to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cassava Sciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-564.6%+564.6%
TTM-564.6%YOY-222.7%-341.9%
TTM-564.6%5Y402,284.2%-402,848.8%
5Y402,284.2%10Y184,387.3%+217,896.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--85.5%+85.5%
TTM-564.6%-171.0%-393.6%
YOY-222.7%-210.0%-12.7%
3Y79,973.7%-289.9%+80,263.6%
5Y402,284.2%-381.1%+402,665.3%
10Y184,387.3%-520.3%+184,907.6%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Cassava Sciences Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Cassava Sciences Inc to theΒ Biotechnology industry mean.
  • -32.7% Return on Assets means thatΒ Cassava Sciences Inc generatedΒ $-0.33 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cassava Sciences Inc:

  • The MRQ is -32.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -19.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-32.7%TTM-19.8%-12.8%
TTM-19.8%YOY-2.5%-17.3%
TTM-19.8%5Y-8.2%-11.6%
5Y-8.2%10Y-10.6%+2.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-32.7%-11.9%-20.8%
TTM-19.8%-11.9%-7.9%
YOY-2.5%-11.2%+8.7%
3Y-10.8%-12.0%+1.2%
5Y-8.2%-11.7%+3.5%
10Y-10.6%-13.8%+3.2%
4.3.1.3. Return on Equity

Shows how efficient Cassava Sciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Cassava Sciences Inc to theΒ Biotechnology industry mean.
  • -50.3% Return on Equity means Cassava Sciences Inc generated $-0.50Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cassava Sciences Inc:

  • The MRQ is -50.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -26.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-50.3%TTM-26.1%-24.2%
TTM-26.1%YOY0.8%-26.9%
TTM-26.1%5Y-9.0%-17.1%
5Y-9.0%10Y-11.6%+2.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-50.3%-14.2%-36.1%
TTM-26.1%-15.2%-10.9%
YOY0.8%-15.3%+16.1%
3Y-12.0%-16.9%+4.9%
5Y-9.0%-17.5%+8.5%
10Y-11.6%-19.6%+8.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Cassava Sciences Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Cassava Sciences Inc is operatingΒ .

  • Measures how much profit Cassava Sciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Cassava Sciences Inc to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cassava Sciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-564.6%+564.6%
TTM-564.6%YOY-242.6%-321.9%
TTM-564.6%5Y419,096.9%-419,661.5%
5Y419,096.9%10Y190,822.5%+228,274.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--154.1%+154.1%
TTM-564.6%-280.2%-284.4%
YOY-242.6%-268.7%+26.1%
3Y96,661.5%-281.5%+96,943.0%
5Y419,096.9%-350.8%+419,447.7%
10Y190,822.5%-530.7%+191,353.2%
4.3.2.2. Operating Ratio

Measures how efficient Cassava Sciences Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cassava Sciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM5.024-5.024
TTM5.024YOY2.426+2.598
TTM5.0245Y-4,280.149+4,285.173
5Y-4,280.14910Y-1,952.802-2,327.347
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.952-1.952
TTM5.0242.974+2.050
YOY2.4263.047-0.621
3Y-984.8313.835-988.666
5Y-4,280.1494.924-4,285.073
10Y-1,952.8026.864-1,959.666
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Cassava Sciences Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Cassava Sciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 2.43Β means the company has $2.43 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cassava Sciences Inc:

  • The MRQ is 2.426. The company is able to pay all its short-term debts. +1
  • The TTM is 6.668. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.426TTM6.668-4.243
TTM6.668YOY5.891+0.778
TTM6.6685Y24.034-17.365
5Y24.03410Y20.684+3.350
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4263.480-1.054
TTM6.6683.790+2.878
YOY5.8914.104+1.787
3Y10.4984.609+5.889
5Y24.0345.764+18.270
10Y20.6846.154+14.530
4.4.3.2. Quick Ratio

Measures if Cassava Sciences Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Cassava Sciences Inc to theΒ Biotechnology industry mean.
  • A Quick Ratio of 2.39Β means the company can pay off $2.39 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cassava Sciences Inc:

  • The MRQ is 2.392. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.261. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.392TTM6.261-3.869
TTM6.261YOY5.574+0.687
TTM6.2615Y23.394-17.134
5Y23.39410Y20.426+2.968
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3922.938-0.546
TTM6.2613.291+2.970
YOY5.5743.928+1.646
3Y9.9824.393+5.589
5Y23.3945.837+17.557
10Y20.4266.549+13.877
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Cassava Sciences Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Cassava Sciences IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Cassava Sciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.35Β means that Cassava Sciences Inc assets areΒ financed with 35.0% credit (debt) and the remaining percentage (100% - 35.0%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Cassava Sciences Inc:

  • The MRQ is 0.350. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.194. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.350TTM0.194+0.156
TTM0.194YOY0.228-0.035
TTM0.1945Y0.108+0.086
5Y0.10810Y0.088+0.020
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3500.339+0.011
TTM0.1940.359-0.165
YOY0.2280.334-0.106
3Y0.1600.341-0.181
5Y0.1080.349-0.241
10Y0.0880.379-0.291
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Cassava Sciences Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Cassava Sciences Inc to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 53.9% means that company has $0.54 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cassava Sciences Inc:

  • The MRQ is 0.539. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.267. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.539TTM0.267+0.272
TTM0.267YOY0.371-0.105
TTM0.2675Y0.153+0.114
5Y0.15310Y0.113+0.039
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5390.391+0.148
TTM0.2670.436-0.169
YOY0.3710.436-0.065
3Y0.2330.461-0.228
5Y0.1530.461-0.308
10Y0.1130.514-0.401
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Cassava Sciences Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Cassava Sciences Inc to theΒ Biotechnology industry mean.
  • A PE ratio of -0.49 means the investor is paying $-0.49Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cassava Sciences Inc:

  • The EOD is -0.568. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.494. Based on the earnings, the company is expensive. -2
  • The TTM is -3.755. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.568MRQ-0.494-0.074
MRQ-0.494TTM-3.755+3.261
TTM-3.755YOY3.297-7.052
TTM-3.7555Y-35.571+31.816
5Y-35.57110Y-25.864-9.707
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.568-2.539+1.971
MRQ-0.494-2.361+1.867
TTM-3.755-2.657-1.098
YOY3.297-3.749+7.046
3Y-5.720-3.883-1.837
5Y-35.571-6.353-29.218
10Y-25.864-7.102-18.762
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cassava Sciences Inc:

  • The EOD is -5.078. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.419. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.472. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.078MRQ-4.419-0.659
MRQ-4.419TTM-6.472+2.054
TTM-6.472YOY-10.176+3.703
TTM-6.4725Y-41.251+34.779
5Y-41.25110Y-32.654-8.597
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.078-3.411-1.667
MRQ-4.419-2.951-1.468
TTM-6.472-3.614-2.858
YOY-10.176-4.421-5.755
3Y-11.842-5.258-6.584
5Y-41.251-8.587-32.664
10Y-32.654-9.639-23.015
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Cassava Sciences Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 0.99 means the investor is paying $0.99Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Cassava Sciences Inc:

  • The EOD is 1.142. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.994. Based on the equity, the company is cheap. +2
  • The TTM is 2.719. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.142MRQ0.994+0.148
MRQ0.994TTM2.719-1.725
TTM2.719YOY7.180-4.461
TTM2.7195Y7.554-4.835
5Y7.55410Y7.729-0.175
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.1422.206-1.064
MRQ0.9942.027-1.033
TTM2.7192.194+0.525
YOY7.1802.425+4.755
3Y5.6962.571+3.125
5Y7.5543.805+3.749
10Y7.7294.462+3.267
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Cassava Sciences Inc.

4.8.1. Institutions holding Cassava Sciences Inc

Institutions are holding 25.196% of the shares of Cassava Sciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31BlackRock Inc7.19340.00013474980-265163-7.0896
2025-06-30Vanguard Group Inc4.49220.00012170072-272235-11.1466
2025-03-31Geode Capital Management, LLC2.12510.00011026599196041.9468
2025-06-30Two Sigma Advisers, LLC2.03610.0037983600750008.2545
2025-03-31State Street Corp1.80910.0001873946-122716-12.3127
2025-03-31JPMorgan Chase & Co1.63540.000179001638868196.847
2025-06-30Goldman Sachs Group Inc1.26920.000261314311683023.5396
2025-03-31Susquehanna International Group, LLP1.14270.000155202127162896.874
2025-03-31UBS Group AG1.12990.0002545815-384911-41.356
2025-06-30Two Sigma Investments LLC1.08990.00175265159393421.7148
2025-06-30GMT Capital Corp0.93170.034145010000
2025-03-31Morgan Stanley - Brokerage Accounts0.7791037635011016041.384
2025-03-31Northern Trust Corp0.7640.0001369090-37472-9.2168
2025-03-31Jane Street Group LLC0.57310.0001276835-123404-30.8326
2025-06-30Charles Schwab Investment Management Inc0.54920.0001265290-95963-26.5639
2025-06-30TANG CAPITAL MANAGEMENT LLC0.49640.02192398203982019.91
2025-03-31Bank of America Corp0.24180116820-362408-75.6233
2025-03-31Bank of New York Mellon Corp0.22910110658-136-0.1228
2025-06-30Squarepoint Ops LLC0.22040.00021064694134563.4866
2025-03-31Group One Trading, LP0.19650.000494925949250
Total 28.90430.063313963064-412481-3.0%

4.9.2. Funds holding Cassava Sciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-07-31Vanguard Total Stock Mkt Idx Inv2.59960.00011255801-27710-2.1589
2025-07-31Vanguard Institutional Extnd Mkt Idx Tr0.96690.0012467084-212836-31.3031
2025-05-31Fidelity Small Cap Index0.74110.00293580093567211.0667
2025-06-30Fidelity Extended Market Index0.51330.0012247963-647-0.2602
2025-07-31Schwab US Small-Cap ETFβ„’0.44110.0026213069-105-0.0493
2025-07-31Vanguard Health Care ETF0.29260.0018141364-1521-1.0645
2025-07-31iShares Micro-Cap ETF0.20410.02489858900
2025-06-30Extended Equity Market Fund K0.18530.001189506-1786-1.9564
2025-06-30Fidelity Total Market Index0.16750.00018089300
2025-06-30Fidelity Series Total Market Index0.13310.000164318-6190-8.7791
2025-06-30Spartan Extended Market Index Pool F0.1070.00115168800
2025-06-30Northern Trust Extended Eq Market Idx0.10590.00125113800
2025-06-30NT Ext Equity Mkt Idx Fd - L0.10590.00125113800
2025-06-30Fidelity Nasdaq Composite Index0.09890.00044779133517234.8115
2025-05-31Spartan Small Cap Index Pool K0.07520.00333632900
2025-06-30Spartan Total Market Index Pool G0.06140.00012966300
2025-07-31Vanguard Balanced Index Inv0.05620.00012712900
2025-06-30T. Rowe Price Extended Equity Market Idx0.05510.00492660000
2025-07-31Schwab US Broad Market ETFβ„’0.05380.00022600000
2025-05-31Fidelity Small Cap Growth Index0.05230.0062527300
Total 7.01630.05443389345-181606-5.4%

5.3. Insider Transactions

Insiders are holding 12.787% of the shares of Cassava Sciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-11-29Eric SchoenSELL598003.86
2024-11-29James William KupiecSELL40003.87
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets135,384
Total Liabilities47,411
Total Stockholder Equity87,973
 As reported
Total Liabilities 47,411
Total Stockholder Equity+ 87,973
Total Assets = 135,384

Assets

Total Assets135,384
Total Current Assets114,821
Long-term Assets20,563
Total Current Assets
Cash And Cash Equivalents 112,381
Net Receivables 835
Other Current Assets 1,605
Total Current Assets  (as reported)114,821
Total Current Assets  (calculated)114,821
+/-0
Long-term Assets
Property Plant Equipment 20,563
Long-term Assets  (as reported)20,563
Long-term Assets  (calculated)20,563
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities47,332
Long-term Liabilities79
Total Stockholder Equity87,973
Total Current Liabilities
Accounts payable 42,822
Other Current Liabilities 4,510
Total Current Liabilities  (as reported)47,332
Total Current Liabilities  (calculated)47,332
+/-0
Long-term Liabilities
Long-term Liabilities Other 79
Long-term Liabilities  (as reported)79
Long-term Liabilities  (calculated)79
+/-0
Total Stockholder Equity
Common Stock48
Retained Earnings -472,738
Other Stockholders Equity 560,663
Total Stockholder Equity (as reported)87,973
Total Stockholder Equity (calculated)87,973
+/-0
Other
Capital Stock48
Cash and Short Term Investments 112,381
Common Stock Shares Outstanding 48,308
Liabilities and Stockholders Equity 135,384
Net Debt -112,381
Net Invested Capital 87,973
Net Working Capital 67,489
Property Plant and Equipment Gross 24,227



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-31
> Total Assets 
22,865
21,139
82,841
81,147
78,831
74,504
71,470
68,136
64,032
60,640
56,691
53,325
48,028
44,531
86,638
80,513
72,425
62,904
55,802
101,192
92,772
83,190
73,774
215,795
215,778
213,243
218,286
208,456
212,245
208,633
208,810
207,625
192,497
179,122
195,497
193,436
189,733
186,316
182,732
182,005
178,597
182,084
180,794
99,195
101,226
102,593
100,592
98,963
96,810
94,440
93,259
56,859
54,870
53,200
51,756
50,103
47,319
45,391
43,591
40,906
39,635
37,756
35,653
31,918
28,626
24,940
22,482
19,302
17,604
14,269
12,377
10,831
11,058
9,833
20,836
20,139
19,523
18,805
18,375
23,486
25,977
25,498
25,399
94,300
284,050
281,305
274,249
266,782
244,191
227,381
207,286
234,834
218,111
197,248
172,529
151,663
155,718
243,568
223,753
157,533
140,932
135,384
135,384140,932157,533223,753243,568155,718151,663172,529197,248218,111234,834207,286227,381244,191266,782274,249281,305284,05094,30025,39925,49825,97723,48618,37518,80519,52320,13920,8369,83311,05810,83112,37714,26917,60419,30222,48224,94028,62631,91835,65337,75639,63540,90643,59145,39147,31950,10351,75653,20054,87056,85993,25994,44096,81098,963100,592102,593101,22699,195180,794182,084178,597182,005182,732186,316189,733193,436195,497179,122192,497207,625208,810208,633212,245208,456218,286213,243215,778215,79573,77483,19092,772101,19255,80262,90472,42580,51386,63844,53148,02853,32556,69160,64064,03268,13671,47074,50478,83181,14782,84121,13922,865
   > Total Current Assets 
22,283
20,073
82,576
79,773
76,585
71,964
68,963
65,714
61,693
58,389
54,530
51,247
46,036
42,625
84,816
78,750
70,540
61,038
53,974
99,656
91,293
81,685
72,087
214,164
214,147
211,693
216,859
207,114
210,254
206,659
206,407
205,374
190,363
177,105
193,598
190,636
187,605
184,255
180,981
178,471
177,714
181,260
180,028
98,484
100,557
101,964
100,084
98,489
96,371
94,037
92,907
56,507
54,518
52,848
51,416
50,103
47,243
45,307
43,510
40,829
39,367
37,502
35,413
31,691
28,413
24,741
22,220
19,070
17,390
14,079
12,204
10,663
10,889
9,699
20,720
20,040
19,265
18,583
18,189
23,349
25,877
25,440
25,071
93,994
283,766
279,558
251,915
244,482
222,200
204,201
183,272
211,226
194,999
174,533
150,184
129,633
133,999
222,122
202,549
136,532
120,151
114,821
114,821120,151136,532202,549222,122133,999129,633150,184174,533194,999211,226183,272204,201222,200244,482251,915279,558283,76693,99425,07125,44025,87723,34918,18918,58319,26520,04020,7209,69910,88910,66312,20414,07917,39019,07022,22024,74128,41331,69135,41337,50239,36740,82943,51045,30747,24350,10351,41652,84854,51856,50792,90794,03796,37198,489100,084101,964100,55798,484180,028181,260177,714178,471180,981184,255187,605190,636193,598177,105190,363205,374206,407206,659210,254207,114216,859211,693214,147214,16472,08781,68591,29399,65653,97461,03870,54078,75084,81642,62546,03651,24754,53058,38961,69365,71468,96371,96476,58579,77382,57620,07322,283
       Cash And Cash Equivalents 
22,179
20,021
81,997
78,927
75,953
71,642
68,442
65,274
61,359
57,806
53,893
50,091
45,664
42,546
46,900
12,027
7,181
3,172
1,750
1,379
107
2,512
1,421
95,651
67,825
51,109
31,558
16,386
61,816
49,191
40,814
86,567
130,807
125,425
143,950
153,158
172,790
145,200
29,169
35,794
50,657
66,773
106,292
4,798
54,894
62,830
71,709
73,144
73,779
79,020
88,240
56,254
51,591
51,545
51,027
49,838
47,102
44,825
42,052
40,590
39,248
36,352
33,993
31,299
26,614
24,626
21,764
18,714
17,264
14,067
11,916
10,479
10,734
9,608
20,444
19,807
19,125
18,534
17,804
23,081
25,600
25,254
24,074
93,506
282,192
278,254
241,524
233,437
209,693
197,232
174,662
201,015
187,467
168,438
142,350
121,136
124,169
207,291
148,978
128,574
117,328
112,381
112,381117,328128,574148,978207,291124,169121,136142,350168,438187,467201,015174,662197,232209,693233,437241,524278,254282,19293,50624,07425,25425,60023,08117,80418,53419,12519,80720,4449,60810,73410,47911,91614,06717,26418,71421,76424,62626,61431,29933,99336,35239,24840,59042,05244,82547,10249,83851,02751,54551,59156,25488,24079,02073,77973,14471,70962,83054,8944,798106,29266,77350,65735,79429,169145,200172,790153,158143,950125,425130,80786,56740,81449,19161,81616,38631,55851,10967,82595,6511,4212,5121071,3791,7503,1727,18112,02746,90042,54645,66450,09153,89357,80661,35965,27468,44271,64275,95378,92781,99720,02122,179
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
36,290
55
63,004
57,820
51,809
98,018
0
79,138
70,126
117,001
141,963
154,232
182,360
188,014
148,144
157,136
165,113
118,504
59,245
51,648
49,240
36,937
12,784
37,017
148,306
139,965
124,876
109,469
73,450
86,428
43,583
38,211
27,651
24,987
22,117
14,922
4,289
6,899
2,800
1,300
1,300
1,250
1,250
250
1,100
0
1,999
950
900
0
1,500
0
550
2,099
2,099
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000002,0992,09955001,50009009501,99901,1002501,2501,2501,3001,3002,8006,8994,28914,92222,11724,98727,65138,21143,58386,42873,450109,469124,876139,965148,30637,01712,78436,93749,24051,64859,245118,504165,113157,136148,144188,014182,360154,232141,963117,00170,12679,138098,01851,80957,82063,0045536,29000000000000000
       Net Receivables 
32
6
8
445
355
255
200
117
96
83
74
55
46
38
0
65,402
65,402
0
-415
98,018
91,034
0
0
889
4,234
6,305
2,596
0
0
0
0
0
0
0
0
0
0
0
0
2,302
0
0
0
7,114
1,996
908
231
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
86
0
1,271
0
0
0
0
0
0
0
0
1,328
1,285
962
1,000
1,439
5,000
947
864
835
8358649475,0001,4391,0009621,2851,328000000001,271086000000000000000000000000000000000002319081,9967,1140002,3020000000000002,5966,3054,2348890091,03498,018-415065,40265,40203846557483961172002553554458632
       Other Current Assets 
72
46
571
0
278
67
321
323
238
500
563
1,101
326
41
1,626
1,321
355
46
415
518
152
35
540
623
125
47
345
2,714
294
332
480
303
311
32
408
541
2,031
2,038
3,506
2,712
2,181
5,018
286
144
84
15
493
358
475
95
378
253
127
3
389
265
141
482
358
239
119
200
520
392
299
115
456
356
126
12
288
184
155
91
276
233
140
49
385
268
277
186
1,683
945
1,574
2,608
10,391
11,045
12,507
6,974
9,918
10,211
7,532
4,767
8,970
7,535
8,830
13,392
48,571
7,011
1,959
1,605
1,6051,9597,01148,57113,3928,8307,5358,9704,7677,53210,2119,9186,97412,50711,04510,3912,6081,5749451,68318627726838549140233276911551842881212635645611529939252020011923935848214126538931272533789547535849315841442865,0182,1812,7123,5062,0382,031541408323113034803322942,7143454712562354035152518415463551,3211,626413261,1015635002383233216727805714672
   > Long-term Assets 
582
1,066
265
0
2,246
2,540
2,506
2,421
2,339
2,251
2,161
2,078
1,992
1,906
1,822
1,763
1,885
1,866
1,828
1,536
1,479
1,505
1,687
1,631
1,631
1,550
1,427
1,342
1,991
1,974
2,403
2,251
2,134
2,017
1,899
2,800
2,128
2,061
1,751
3,534
883
824
766
711
669
629
508
474
439
403
352
352
352
352
340
7,504
76
84
81
77
268
254
240
227
213
199
262
232
214
190
173
168
169
134
116
99
258
222
186
137
100
58
330
306
284
1,747
22,334
22,300
21,991
23,180
24,014
23,608
23,112
22,715
22,345
22,030
21,719
21,446
21,204
21,001
20,781
20,563
20,56320,78121,00121,20421,44621,71922,03022,34522,71523,11223,60824,01423,18021,99122,30022,3341,7472843063305810013718622225899116134169168173190214232262199213227240254268778184767,5043403523523523524034394745086296697117668248833,5341,7512,0612,1282,8001,8992,0172,1342,2512,4031,9741,9911,3421,4271,5501,6311,6311,6871,5051,4791,5361,8281,8661,8851,7631,8221,9061,9922,0782,1612,2512,3392,4212,5062,5402,24602651,066582
       Property Plant Equipment 
122
124
265
1,299
2,171
2,465
2,431
2,346
2,264
2,176
2,086
2,003
1,917
1,831
1,747
1,688
1,810
1,791
1,753
1,461
1,404
1,430
1,612
1,556
1,556
1,475
1,352
1,267
1,223
1,206
1,549
1,607
1,490
1,373
1,256
774
708
641
578
517
457
398
340
285
232
192
157
122
87
52
352
0
0
0
0
0
76
72
69
100
256
242
228
200
201
187
250
300
214
190
173
200
139
122
104
100
246
210
174
137
100
58
330
306
284
327
20,926
20,826
21,051
22,321
23,274
22,986
22,609
22,328
22,077
21,854
21,604
21,364
21,135
20,964
20,781
20,563
20,56320,78120,96421,13521,36421,60421,85422,07722,32822,60922,98623,27422,32121,05120,82620,926327284306330581001371742102461001041221392001731902143002501872012002282422561006972760000035252871221571922322853403984575175786417087741,2561,3731,4901,6071,5491,2061,2231,2671,3521,4751,5561,5561,6121,4301,4041,4611,7531,7911,8101,6881,7471,8311,9172,0032,0862,1762,2642,3462,4312,4652,1711,299265124122
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,209
1,075
940
859
740
622
503
387
268
176
115
82
69
37
0
0
003769821151762683875036227408599401,0751,20900000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Long-term Assets Other 
460
942
0
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
768
768
854
644
644
644
643
2,026
1,420
1,420
1,173
3,017
426
426
426
426
437
437
351
352
352
351
352
352
352
352
340
7,504
0
12
12
-23
12
12
12
27
12
12
12
-68
232
0
0
-32
30
12
12
-1
12
12
12
90
67
45
0
295
274
1,420
199
399
188
166
144
0
0
0
0
0
0
0
0
0
0
0
000000000001441661883991991,4202742950456790121212-1121230-3200232-6812121227121212-23121207,5043403523523523523513523523514374374264264264263,0171,1731,4201,4202,026643644644644854768768757575757575757575757575757575757575757575757575750942460
> Total Liabilities 
488
720
1,352
2,452
2,600
1,487
1,386
2,519
1,993
2,003
1,460
3,101
2,319
2,395
4,018
3,951
5,820
5,161
7,127
7,796
8,221
8,253
7,635
152,435
149,498
144,191
136,950
130,541
121,120
115,122
109,762
103,711
100,174
95,735
92,983
89,150
85,557
80,463
76,671
73,753
68,647
71,398
69,603
66,262
62,829
59,562
57,106
54,570
51,512
48,271
46,927
43,723
41,460
39,025
37,504
1,801
1,618
1,739
2,383
850
1,200
1,813
2,586
2,551
3,344
1,953
2,167
665
883
999
1,010
1,132
758
1,287
862
511
970
982
930
1,387
1,145
1,314
1,426
2,100
2,863
4,825
6,684
12,867
7,097
9,011
8,567
7,295
14,106
17,895
17,414
14,195
77,121
54,594
57,114
11,829
13,316
47,411
47,41113,31611,82957,11454,59477,12114,19517,41417,89514,1067,2958,5679,0117,09712,8676,6844,8252,8632,1001,4261,3141,1451,3879309829705118621,2877581,1321,0109998836652,1671,9533,3442,5512,5861,8131,2008502,3831,7391,6181,80137,50439,02541,46043,72346,92748,27151,51254,57057,10659,56262,82966,26269,60371,39868,64773,75376,67180,46385,55789,15092,98395,735100,174103,711109,762115,122121,120130,541136,950144,191149,498152,4357,6358,2538,2217,7967,1275,1615,8203,9514,0182,3952,3193,1011,4602,0031,9932,5191,3861,4872,6002,4521,352720488
   > Total Current Liabilities 
488
720
1,352
2,452
2,600
1,487
1,386
2,519
1,993
2,003
1,460
3,101
2,319
2,395
4,018
3,951
5,820
5,161
7,127
7,796
8,221
8,253
7,635
32,347
35,960
37,203
36,512
36,654
33,023
33,575
34,762
20,657
20,706
19,854
20,683
20,114
19,577
18,069
18,110
18,511
12,692
13,760
14,689
14,071
13,361
12,818
13,085
13,272
12,938
12,421
13,800
9,999
9,694
9,218
9,655
1,801
1,618
1,739
2,383
850
1,200
1,813
2,586
2,551
3,344
1,953
2,167
665
883
999
1,010
1,132
758
1,287
862
511
902
937
907
1,387
1,145
1,314
1,168
1,865
2,650
4,637
6,326
12,534
6,789
8,722
8,308
7,063
13,909
17,895
17,414
14,195
77,121
54,594
57,034
11,750
13,237
47,332
47,33213,23711,75057,03454,59477,12114,19517,41417,89513,9097,0638,3088,7226,78912,5346,3264,6372,6501,8651,1681,3141,1451,3879079379025118621,2877581,1321,0109998836652,1671,9533,3442,5512,5861,8131,2008502,3831,7391,6181,8019,6559,2189,6949,99913,80012,42112,93813,27213,08512,81813,36114,07114,68913,76012,69218,51118,11018,06919,57720,11420,68319,85420,70620,65734,76233,57533,02336,65436,51237,20335,96032,3477,6358,2538,2217,7967,1275,1615,8203,9514,0182,3952,3193,1011,4602,0031,9932,5191,3861,4872,6002,4521,352720488
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,295
6,690
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,820
0
0
576
0
0
0
0
793
929
0
0
742
41,760
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
180
180
180
180
134
90
116
116
168
186
190
97
99
200
204
104
0
0
0
0
0
0
0
0
0
0
00000000001042042009997190186168116116901341801801801800000000000000000000041,760742009297930000576007,820000000000000006,6906,29500000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
90
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000900000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
488
720
1,352
0
2,405
1,343
1,231
2,170
1,446
1,406
1,072
2,648
1,728
1,731
3,537
3,441
5,105
817
831
877
904
1,006
564
998
820
596
438
985
840
2,220
3,008
3,624
2,962
3,206
3,485
2,216
1,685
975
1,005
1,317
485
625
715
1,107
436
604
556
464
502
501
507
1,290
366
435
1,273
1,086
428
360
822
173
255
465
898
1,034
1,043
378
1,083
303
573
658
712
424
421
962
549
294
495
594
340
453
608
416
465
911
864
1,912
2,345
7,126
3,332
4,758
3,534
4,017
8,242
10,338
9,492
10,573
9,603
52,552
52,244
7,654
8,192
42,822
42,8228,1927,65452,24452,5529,60310,5739,49210,3388,2424,0173,5344,7583,3327,1262,3451,9128649114654166084533405944952945499624214247126585733031,0833781,0431,0348984652551738223604281,0861,2734353661,2905075015024645566044361,1077156254851,3171,0059751,6852,2163,4853,2062,9623,6243,0082,2208409854385968209985641,0069048778318175,1053,4413,5371,7311,7282,6481,0721,4061,4462,1701,2311,3432,40501,352720488
       Other Current Liabilities 
0
0
0
0
195
144
155
349
547
597
388
453
591
664
481
510
715
4,344
6,296
6,919
7,317
7,247
7,071
5,149
8,940
6,050
6,295
6,690
5,983
5,155
5,554
2,685
3,396
2,300
2,850
3,550
3,544
2,746
2,757
2,846
2,110
2,238
10,897
2,067
2,028
1,317
1,632
1,911
1,539
1,023
2,396
1,806
1,496
951
1,292
1,356
1,190
1,379
1,561
-30,794
945
1,348
1,688
13,903
2,301
1,575
1,084
14,507
310
341
298
708
337
325
313
217
227
163
387
754
403
808
587
838
1,618
2,539
3,791
5,311
3,358
3,764
4,570
2,942
5,667
7,557
7,922
3,622
67,518
2,042
4,790
4,096
5,045
4,510
4,5105,0454,0964,7902,04267,5183,6227,9227,5575,6672,9424,5703,7643,3585,3113,7912,5391,61883858780840375438716322721731332533770829834131014,5071,0841,5752,30113,9031,6881,348945-30,7941,5611,3791,1901,3561,2929511,4961,8062,3961,0231,5391,9111,6321,3172,0282,06710,8972,2382,1102,8462,7572,7463,5443,5502,8502,3003,3962,6855,5545,1555,9836,6906,2956,0508,9405,1497,0717,2477,3176,9196,2964,3447155104816645914533885975473491551441950000
   > Long-term Liabilities 
488
720
1,352
0
2,405
1,343
1,231
2,170
1,446
1,406
1,072
2,648
1,728
1,731
3,537
3,441
5,105
817
831
877
904
1,006
564
120,088
113,538
106,988
100,438
93,887
88,097
81,547
75,000
83,054
79,468
75,881
72,300
69,036
65,980
62,394
58,561
55,242
55,955
57,638
54,914
52,191
49,468
46,744
44,021
41,298
38,574
35,850
33,127
33,724
31,766
29,807
27,849
445
428
360
822
173
255
465
898
1,034
1,043
378
1,083
303
573
658
712
424
421
962
549
294
68
45
23
543
675
461
258
235
213
188
358
333
308
289
259
232
197
0
0
0
0
0
80
79
79
79
79797980000001972322592893083333581882132352584616755432345682945499624214247126585733031,0833781,0431,03489846525517382236042844527,84929,80731,76633,72433,12735,85038,57441,29844,02146,74449,46852,19154,91457,63855,95555,24258,56162,39465,98069,03672,30075,88179,46883,05475,00081,54788,09793,887100,438106,988113,538120,0885641,0069048778318175,1053,4413,5371,7311,7282,6481,0721,4061,4462,1701,2311,3432,40501,352720488
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
194
194
194
201
197
197
0
0
0
0
0
0
0
0
0
0
000000000019719720119419419400000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
46,312
43,587
41,298
38,574
35,850
33,127
33,724
31,766
29,807
27,849
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000000027,84929,80731,76633,72433,12735,85038,57441,29843,58746,312000000000000000000000000000000000000000000000
> Total Stockholder Equity
22,377
20,418
81,489
0
76,231
73,017
70,084
65,616
62,038
58,636
55,231
50,224
45,709
42,136
82,620
76,562
66,605
57,743
48,675
93,396
84,551
74,937
66,139
63,360
66,280
69,052
81,336
77,915
91,125
93,511
99,048
103,914
92,323
83,387
102,514
104,286
104,176
105,853
106,061
108,252
109,950
110,686
111,191
32,933
38,397
43,031
43,486
44,393
45,298
46,169
46,332
13,136
13,410
14,175
14,252
48,302
45,701
43,652
41,208
40,056
38,435
35,943
33,067
29,367
25,282
22,987
20,315
18,637
16,721
13,270
11,367
9,699
10,300
8,546
19,974
19,628
18,553
17,823
17,445
22,099
24,832
24,184
23,973
92,200
281,187
276,480
267,565
253,915
237,094
218,370
198,719
227,539
204,005
179,353
155,115
137,468
78,597
188,974
166,639
145,704
127,616
87,973
87,973127,616145,704166,639188,97478,597137,468155,115179,353204,005227,539198,719218,370237,094253,915267,565276,480281,18792,20023,97324,18424,83222,09917,44517,82318,55319,62819,9748,54610,3009,69911,36713,27016,72118,63720,31522,98725,28229,36733,06735,94338,43540,05641,20843,65245,70148,30214,25214,17513,41013,13646,33246,16945,29844,39343,48643,03138,39732,933111,191110,686109,950108,252106,061105,853104,176104,286102,51483,38792,323103,91499,04893,51191,12577,91581,33669,05266,28063,36066,13974,93784,55193,39648,67557,74366,60576,56282,62042,13645,70950,22455,23158,63662,03865,61670,08473,01776,231081,48920,41822,377
   Common Stock
10
10
27
0
27
27
27
27
27
27
27
27
27
27
35
35
35
36
36
44
44
44
44
44
44
44
44
44
44
44
44
44
42
41
42
42
42
42
42
42
43
43
43
43
44
45
45
45
45
45
45
45
45
45
151,373
45
153,257
154,454
45
46
157,510
46
46
46
46
162,435
163,280
46
46
7
7
7
7
7
17
17
183,868
17
17
190,686
25
25
26
267,121
459,634
460,052
460,699
461,221
40
462,531
463,137
511,091
511,828
513,552
514,965
42
43
48
48
48
48
48
48484848484342514,965513,552511,828511,091463,137462,53140461,221460,699460,052459,634267,121262525190,6861717183,8681717777774646163,280162,43546464646157,5104645154,454153,25745151,37345454545454545454544434343434242424242424142444444444444444444444444443636353535272727272727272727270271010
   Retained Earnings Total Equity00000000-334,199-307,8230-264,418-244,161-224,833-207,306-193,134-183,572-178,447-174,9210-170,873-169,737-168,587-167,071-166,374-165,315-163,956-163,279-162,012-159,559-157,399-154,982-152,391-148,231-145,488-142,966-139,448-136,433-130,638-126,121-122,450-119,076-116,493-114,337-110,802-107,557-104,107-137,122-136,360-136,059-135,651-133,857-132,306-132,175-132,205-131,814-130,999000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
-8,572
-7,099
-6,914
-49
-3,768
-2,893
-2,406
-1,914
-1,480
-1,279
-1,388
-426
-318
-68
-1
43
157
-267
-122
-544
-823
-472
-512
-479
-815
-1,130
-291
-372
103
-177
354
584
905
465
-183
325
195
99
-31
347
664
473
693
525
468
394
121
128
96
43
2
4
1
1
1
1
1
0
1
1
1
1
1
-700
0
0
1
-700
-700
0
0
-800
0
0
0
-900
-900
0
0
-900
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000-90000-900-900000-80000-700-700100-70011111011111424396128121394468525693473664347-3199195325-183465905584354-177103-372-291-1,130-815-479-512-472-823-544-122-26715743-1-68-318-426-1,388-1,279-1,480-1,914-2,406-2,893-3,768-49-6,914-7,099-8,572
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
173,591
175,134
176,425
177,332
178,387
180,142
148,738
149,423
150,489
151,328
152,363
153,212
154,409
155,499
156,502
157,464
158,346
159,141
159,959
161,669
162,389
163,234
164,079
164,906
165,654
166,342
167,091
169,852
170,551
183,236
183,567
183,851
184,180
184,499
190,664
194,544
195,032
0
267,086
459,594
460,012
460,659
461,181
461,887
462,491
463,097
0
511,786
513,510
0
0
0
0
0
0
0
0
00000000513,510511,7860463,097462,491461,887461,181460,659460,012459,594267,0860195,032194,544190,664184,499184,180183,851183,567183,236170,551169,852167,091166,342165,654164,906164,079163,234162,389161,669159,959159,141158,346157,464156,502155,499154,409153,212152,363151,328150,489149,423148,738180,142178,387177,332176,425175,134173,591000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
17,698
17,780
107,857
0
104,533
103,529
103,478
104,209
104,223
104,334
104,088
103,254
103,248
103,770
150,149
150,732
150,824
151,452
151,469
205,920
205,943
206,160
206,168
206,489
208,868
210,588
212,378
214,749
215,595
216,077
217,910
221,415
214,238
210,785
215,369
218,021
219,865
221,672
223,322
225,432
227,832
229,563
230,569
161,957
167,684
173,591
175,134
176,425
177,332
178,387
180,142
148,738
149,423
150,489
151,328
152,363
153,212
154,409
155,499
156,502
157,464
158,346
159,141
159,959
161,669
162,389
163,234
164,079
164,906
165,654
166,342
167,091
169,852
170,551
183,236
183,567
183,851
184,180
184,499
190,664
194,544
195,032
196,250
267,086
459,594
460,012
460,659
461,181
461,887
462,491
463,097
511,049
511,786
513,510
514,923
518,195
434,280
538,497
544,105
550,767
556,082
560,663
560,663556,082550,767544,105538,497434,280518,195514,923513,510511,786511,049463,097462,491461,887461,181460,659460,012459,594267,086196,250195,032194,544190,664184,499184,180183,851183,567183,236170,551169,852167,091166,342165,654164,906164,079163,234162,389161,669159,959159,141158,346157,464156,502155,499154,409153,212152,363151,328150,489149,423148,738180,142178,387177,332176,425175,134173,591167,684161,957230,569229,563227,832225,432223,322221,672219,865218,021215,369210,785214,238221,415217,910216,077215,595214,749212,378210,588208,868206,489206,168206,160205,943205,920151,469151,452150,824150,732150,149103,770103,248103,254104,088104,334104,223104,209103,478103,529104,5330107,85717,78017,698



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-1,132
Gross Profit-1,132-1,132
 
Operating Income (+$)
Gross Profit-1,132
Operating Expense-150,214
Operating Income-151,346-151,346
 
Operating Expense (+$)
Research Development69,637
Selling General Administrative71,809
Selling And Marketing Expenses0
Operating Expense150,214141,446
 
Net Interest Income (+$)
Interest Income8,510
Interest Expense-0
Other Finance Cost-0
Net Interest Income8,510
 
Pretax Income (+$)
Operating Income-151,346
Net Interest Income8,510
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-24,342-278,350
EBIT - interestExpense = -24,342
-24,342
-24,342
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-24,342-24,342
Earnings Before Interest and Taxes (EBITDA)-23,210
 
After tax Income (+$)
Income Before Tax-24,342
Tax Provision-0
Net Income From Continuing Ops-24,342-24,342
Net Income-24,342
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses151,346
Total Other Income/Expenses Net127,004-8,510
 

Technical Analysis of Cassava Sciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cassava Sciences Inc. The general trend of Cassava Sciences Inc is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cassava Sciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Cassava Sciences Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Cassava Sciences Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 2.11 < 2.4 < 2.43.

The bearish price targets are: 2.05 > 2.04 > 2.04.

Know someone who trades $SAVA? Share this with them.πŸ‘‡

Cassava Sciences Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Cassava Sciences Inc. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Cassava Sciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Cassava Sciences Inc. The current macd is -0.03850082.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cassava Sciences Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Cassava Sciences Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Cassava Sciences Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Cassava Sciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartCassava Sciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Cassava Sciences Inc. The current adx is 9.40925284.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Cassava Sciences Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Cassava Sciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Cassava Sciences Inc. The current sar is 2.31459921.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Cassava Sciences Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Cassava Sciences Inc. The current rsi is 42.69. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Cassava Sciences Inc Daily Relative Strength Index (RSI) ChartCassava Sciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Cassava Sciences Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cassava Sciences Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Cassava Sciences Inc Daily Stochastic Oscillator ChartCassava Sciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Cassava Sciences Inc. The current cci is -90.74387724.

Cassava Sciences Inc Daily Commodity Channel Index (CCI) ChartCassava Sciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Cassava Sciences Inc. The current cmo is -22.47852125.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Cassava Sciences Inc Daily Chande Momentum Oscillator (CMO) ChartCassava Sciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Cassava Sciences Inc. The current willr is -88.88888889.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Cassava Sciences Inc Daily Williams %R ChartCassava Sciences Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Cassava Sciences Inc.

Cassava Sciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Cassava Sciences Inc. The current atr is 0.10219496.

Cassava Sciences Inc Daily Average True Range (ATR) ChartCassava Sciences Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Cassava Sciences Inc. The current obv is -207,092,037.

Cassava Sciences Inc Daily On-Balance Volume (OBV) ChartCassava Sciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Cassava Sciences Inc. The current mfi is 30.35.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Cassava Sciences Inc Daily Money Flow Index (MFI) ChartCassava Sciences Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Cassava Sciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-12BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-27MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-01MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-07-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-22BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-25ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-08-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-08-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-08-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-09-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-09-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-09-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Cassava Sciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Cassava Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.687
Ma 20Greater thanMa 502.180
Ma 50Greater thanMa 1002.232
Ma 100Greater thanMa 2002.083
OpenGreater thanClose2.100
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Cassava Sciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Cassava Sciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cassava Sciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Cassava Sciences Inc

I send you an email if I find something interesting about Cassava Sciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Cassava Sciences Inc.

Receive notifications about Cassava Sciences Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.